Featured Research

from universities, journals, and other organizations

Researchers Determine Reason For Deadly Spread Of 1918 Influenza

Date:
February 6, 2004
Source:
Howard Hughes Medical Institute
Summary:
The explosive spread of the influenza virus during the 1918 pandemic that killed some 20 million people worldwide was likely enabled by the unique structure of a protein on the virus's surface, researchers are reporting.

The explosive spread of the influenza virus during the 1918 pandemic that killed some 20 million people worldwide was likely enabled by the unique structure of a protein on the virus's surface, researchers are reporting. The newly determined structure of the viral protein reveals that the 1918 strain of influenza underwent subtle alterations that enabled it to bind with deadly efficiency to human cells, while retaining the basic properties of the avian virus from which it evolved.

According to the researchers, although their findings do not apply to the new virulent strain of avian flu that is threatening to spread, they do emphasize how subtle alterations in the influenza virus's infectivity could spawn a major epidemic.

The findings were the result of a long-term collaboration between the late Don Wiley, a Howard Hughes Medical Institute investigator at Harvard University who died in an accident in 2001, and Sir John Skehel of the Medical Research Council's National Institute for Medical Research in London. Their studies were published February 5, 2004, in ScienceExpress, the online version the journal Science.

In their study, the researchers sought to understand the structure of the hemagglutinin protein, which covers the surface of the influenza virus and is known to initiate the first stages of viral infection. The protein does so by recognizing and binding to receptors on the cell surface that contain molecules called sialic acids. After hemagglutinin binds to these receptors, it causes pores to open in the human cells, allowing the virus to pass through.

According to Skehel, the researchers sought to understand how the 1918 version of hemagglutinin could bind to receptors on human cells, yet still retain many characteristics of its avian precursor virus.

"The 1918 virus was the first of this particular group of virus that caused a pandemic," said Skehel. He said that the hemagglutinin in the 1918 virus was designated H1, and the influenza viruses that caused later pandemics had distinctively different hemagglutinin structures -- designated H2 for the Asian influenza that began in 1957 and H3 for the Hong Kong strain, which began in 1968. "What was interesting was that, although all three of these subtypes came from birds, the H1 was quite different from H2 and H3, having hardly changed from what it was in the avian virus," he said.

The researchers set out to explore this difference in detail, working from DNA sequence information that other researchers had gleaned from viral material isolated from autopsy samples preserved from the 1918 pandemic. Such scientific detective work was necessary because the virus had apparently gone extinct and had not been preserved in specimens from that era.

Using this sequence data, Wiley, Skehel, and their colleagues synthesized the gene for the H1 hemagglutinin and used it to produce the protein itself. They then crystallized the protein and used the analytical technique of x-ray crystallography to determine its structure.

"The structure revealed how this H1 group could still resemble the avian binding site, but nevertheless infect humans," said Skehel. "We found basically that two sides of the hemagglutinin receptor binding site are in slightly different positions in the 1918 hemagglutinin, in comparison with the Hong Kong protein," said Skehel. "This subtle difference allows the human receptor to bind in an antigenically favorable way."

According to Skehel, the hemagglutinin of the current strain of avian flu that has killed people in Asia exposed to infected birds is closer to that of the Hong Kong flu. "But presumably, what's blocking this current flu from spreading person-to-person is that its hemagglutinin structure has not yet evolved such that it can efficiently infect humans," said Skehel.

The researchers concluded that the hemagglutinin structure they uncovered for the 1918 virus may well have been a key contributor to its deadly spread. "With the ability to ensure the efficiency of the initial stages of virus infection, coupled with novel antigenicity, the human-1918 [hemagglutinin] may have been the prime determinant of extensive mortality in the 1918 pandemic," the researchers wrote in ScienceExpress.


Story Source:

The above story is based on materials provided by Howard Hughes Medical Institute. Note: Materials may be edited for content and length.


Cite This Page:

Howard Hughes Medical Institute. "Researchers Determine Reason For Deadly Spread Of 1918 Influenza." ScienceDaily. ScienceDaily, 6 February 2004. <www.sciencedaily.com/releases/2004/02/040206080420.htm>.
Howard Hughes Medical Institute. (2004, February 6). Researchers Determine Reason For Deadly Spread Of 1918 Influenza. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2004/02/040206080420.htm
Howard Hughes Medical Institute. "Researchers Determine Reason For Deadly Spread Of 1918 Influenza." ScienceDaily. www.sciencedaily.com/releases/2004/02/040206080420.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins